Type 1 vs Type 2

Respiratory failure is divided by the arterial blood gas. Type 1 (hypoxemic) respiratory failure is defined by a low arterial oxygen (PaO2 below 60 mm Hg) with a normal or low carbon dioxide, reflecting a problem with gas exchange across the alveoli. Type 2 (hypercapnic) respiratory failure adds an elevated PaCO2 (above 50 mm Hg), reflecting inadequate ventilation to clear carbon dioxide. The two often overlap.

Causes

Type 1 failure results from conditions that impair oxygenation despite preserved effort — pneumonia, pulmonary edema, ARDS, and pulmonary embolism — typically through ventilation-perfusion mismatch or shunt. Type 2 failure results from inadequate ventilation — a "pump" problem — as in COPD exacerbations, drug overdose depressing the respiratory drive, neuromuscular disease, and severe asthma with fatigue. Recognizing which type points to the cause.

Diagnosis

The arterial blood gas is central: it establishes the PaO2 and PaCO2, classifies the type, and shows the acid-base status (acute hypercapnia causes respiratory acidosis). Pulse oximetry monitors oxygenation continuously, and the underlying cause is sought with imaging, history, and examination. Signs of increasing work of breathing and fatigue help judge how urgently support is needed.

Management

Treatment supports gas exchange while the underlying cause is treated. Supplemental oxygen corrects hypoxemia in type 1 failure (titrated cautiously in chronic CO2 retainers). Type 2 failure with respiratory acidosis often responds to noninvasive positive-pressure ventilation (such as BiPAP), which assists ventilation. When these fail or the patient cannot protect the airway, intubation and invasive mechanical ventilation are required.